CEACAM5 and gastric cancer: In summary, the performance of plasma mSEPT9 was better than that of CEA, CA19-9, and CA72-4 and could be considered a useful and noninvasive biomarker for diagnosing GC and distinguishing between benign and malignant diseases of the stomach, especially for patients with poor basic conditions who are unable to tolerate gastroscopy.